Literature DB >> 7545392

LFA-3 delta D2: a novel in vivo isoform of lymphocyte function-associated antigen 3.

A C Kirby1, V Hill, I Olsen, S R Porter.   

Abstract

Lymphocyte function-associated antigen 3 (LFA-3) has previously been described as occurring as two isomers in vivo, a transmembrane (TM) form and a glycosyl phosphatidylinositol (GPI)-linked form, differing only in their membrane anchoring mechanism. A third isoform, LFA-3 delta D2, which has the cytoplasmic tail of TM LFA-3 but a truncated extracellular domain, has been identified in vitro. We report that the LFA-3 delta D2 isoform, identified by RT-PCR analysis and DNA sequencing, is also present in vivo and appears to share a signal sequence with the TM and GPI isoforms. Expression of LFA-3 delta D2 was observed in both normal and diseased human buccal mucosa and gingiva. Thus, while specific functional differences between isoforms remain to be established, our results show that LFA-3 delta D2 is constitutively expressed in vivo, along with the other, previously described, isoforms of LFA-3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545392     DOI: 10.1006/bbrc.1995.2275

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells.

Authors:  Roghieh Djafarzadeh; Matthias Sauter; Susan Notohamiprodjo; Elfriede Noessner; Pankaj Goyal; Wolfgang Siess; Markus Wörnle; Andrea Ribeiro; Susanne Himmelein; Thomas Sitter; Peter J Nelson
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

2.  Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.

Authors:  Q Bao; H Niess; R Djafarzadeh; Y Zhao; B Schwarz; M K Angele; K-W Jauch; P J Nelson; C J Bruns
Journal:  Target Oncol       Date:  2013-08-10       Impact factor: 4.493

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.